TY - JOUR
T1 - Facing points of view
T2 - Representations on adjuvant endocrine therapy of premenopausal patients after breast cancer and their healthcare providers in France. The FOR-AD study
AU - Roche, Nicolas
AU - Le Provost, Jean Bernard
AU - Borinelli-Franzoi, Maria Alice
AU - Boinon, Diane
AU - Martin, Elise
AU - Menvielle, Gwenn
AU - Dumas, Agnès
AU - Rivera, Sofia
AU - Conversano, Angelica
AU - Matias, Margarida
AU - Viansone, Alessandro
AU - Di Meglio, Antonio
AU - Delaloge, Suzette
AU - Vaz-Duarte-Luis, Ines Maria
AU - Pistilli, Barbara
AU - Fasse, Léonor
N1 - Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2023/2/1
Y1 - 2023/2/1
N2 - Purpose: Adjuvant endocrine therapy (ET) for 5–10 years is the backbone of the therapeutic strategy in patients with hormone receptor positive (HR+) early breast cancer (BC). However, long-term adherence to adjuvant ET represents a major challenge for most patients. According to prior studies, side effects of adjuvant ET are an important reason for poor adherence. In contrast, better communication and relational bond between patients and healthcare providers (HCPs) may improve adherence. The FOR-AD (Focus on non-adherence) study aimed at better understanding the representation of adjuvant ET by patients and their HCPs, in order to improve the care process. Methods: Three focus groups of premenopausal women (receiving adjuvant ET for variable amount of time) and two focus groups of HCPs (including oncologists, pharmacists, and nurses) were conducted, each including around ten participants. Thematic analyses using a general inductive approach were constructed to report participants’ representations. Results: Two main themes emerged across groups, and appeared of major importance. Representations on adjuvant ET were often homogenous within each group, but differed between patients and their HCPs. The relationship between both groups was considerably discussed, particularly its importance in facilitating adherence to adjuvant ET. Suggestions on improving the care process were also given, such as systematically including psychologists in follow-up care paths and having a nurse navigator follow patients under treatment with adjuvant ET. Conclusion: The present qualitative exploration may help buildi future tailored interventions to improve adherence to adjuvant ET, in particular regarding the role of nurse navigators.
AB - Purpose: Adjuvant endocrine therapy (ET) for 5–10 years is the backbone of the therapeutic strategy in patients with hormone receptor positive (HR+) early breast cancer (BC). However, long-term adherence to adjuvant ET represents a major challenge for most patients. According to prior studies, side effects of adjuvant ET are an important reason for poor adherence. In contrast, better communication and relational bond between patients and healthcare providers (HCPs) may improve adherence. The FOR-AD (Focus on non-adherence) study aimed at better understanding the representation of adjuvant ET by patients and their HCPs, in order to improve the care process. Methods: Three focus groups of premenopausal women (receiving adjuvant ET for variable amount of time) and two focus groups of HCPs (including oncologists, pharmacists, and nurses) were conducted, each including around ten participants. Thematic analyses using a general inductive approach were constructed to report participants’ representations. Results: Two main themes emerged across groups, and appeared of major importance. Representations on adjuvant ET were often homogenous within each group, but differed between patients and their HCPs. The relationship between both groups was considerably discussed, particularly its importance in facilitating adherence to adjuvant ET. Suggestions on improving the care process were also given, such as systematically including psychologists in follow-up care paths and having a nurse navigator follow patients under treatment with adjuvant ET. Conclusion: The present qualitative exploration may help buildi future tailored interventions to improve adherence to adjuvant ET, in particular regarding the role of nurse navigators.
KW - Breast cancer
KW - Endocrine therapy
KW - Nurse navigators
KW - Representations
KW - Treatment adherence
UR - http://www.scopus.com/inward/record.url?scp=85145846459&partnerID=8YFLogxK
U2 - 10.1016/j.ejon.2022.102259
DO - 10.1016/j.ejon.2022.102259
M3 - Article
C2 - 36623339
AN - SCOPUS:85145846459
SN - 1462-3889
VL - 62
JO - European Journal of Oncology Nursing
JF - European Journal of Oncology Nursing
M1 - 102259
ER -